CannabisNewsBreaks – O’Cannabiz International Conference and Expo Slated for June Return to Toronto

The O’Cannabiz International Conference and Expo is heading back to Toronto this year; the three-day event is scheduled for June 1–3, 2022. The event is designed for cannabis industry entrepreneurs, growers, researchers, suppliers and retailers, as well as cannabis product consumers. Participants will learn about an array of diverse topics covered in more than 70 breakout sessions and workshops and discussed by more than 180 presenters. In addition, the event features a 50,000,000-square-foot expo hall that spotlights hundreds of exhibitors coming from all corners of the cannabis industry. The event networking opportunities are also invaluable. “We’re pleased to announce we’re back after the unavoidable COVID-19 rescheduling,” said O’Cannabiz CEO Danya Dixon in the press release. “As Canada’s premier cannabis event, we’re excited to welcome back all of our committed partners, sponsors, exhibitors and ticket holders. We appreciate your continued patience and understanding through this transitionary period. Your support has been immensely important and will be a key part of making the 2022 O’Cannabiz Conference and Expo the must-attend event for everyone in the cannabis community.”

To attend the event, visit https://cnw.fm/0vYle

To view the full press release, visit https://cnw.fm/aotuv

About O’Cannabiz Conference & Expo

Voted the no. 1 cannabis event in Canada by “High! Canada” magazine, O’Cannabiz is known for its ability to showcase and promote the people, businesses and brands that are making a difference as cannabis continues its path toward global acceptance. Many of these visionaries will be celebrated during the second annual O’Cannabiz Industry Awards Gala, slated for the evening of June 1, 2022. The producers of O’Cannabiz have decades of experience producing national profile events and creating global connections between business communities in the arts, broadcasting, media, and technology. They have organized trade summit initiatives with governments around the world and have worked closely with sponsors at all levels of the Canadian government. For more information, visit www.OCannabiz.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Congress Appoints Negotiators to Finalize Manufacturing Bill with Possible Cannabis Banking Protections

Cannabis banking has been a contentious issue since states started legalizing medical and recreational cannabis. Since federal law prohibits the cultivation, production and sale of cannabis, most financial institutions refuse to work with businesses in the cannabis space. This forces marijuana businesses to operate on a cash-only basis, which significantly increases the risk of robberies and prevents these companies from accessing much-needed capital.

After years of advocating for access to financial services, the cannabis sector is a step closer to its goal after Congress appointed negotiators to finalize a manufacturing and innovation bill that would protect banks that choose to service cannabis businesses. Additionally, Rep Maxine Waters, who chairs the House Financial Services Committee, has listed the Secure and Fair Enforcement (SAFE) Act as a priority for the panel. In a recent press release, the committee noted that operating on a cash basis has led to significant public safety risks and makes it easier to engage in money laundering and tax evasion.

According to Safe Banking Act sponsor Ed Perlmutter, more than two-thirds of the America COMPETES Act Conferees have voted for or cosponsored the SAFE Banking Act. Even though he wasn’t appointed to the conference, Perlmutter says that he appreciates the support his legislation has received from the Financial Services Committee.

He says that it is now time to raise awareness of the public safety problem caused by the lack of access to banking in the cannabis space and to include his cannabis banking legislation in the America COMPETES package. The House of Representatives has passed some form of the SAFE Banking Act six times, but the legislation has repeatedly stalled in the Senate.

Alternatively, history may well repeat itself, and the bill could fail to advance past the Senate. Senate majority leader Chuck Schumer has made it clear that he would rather pass comprehensive cannabis reform before a cannabis banking bill. In December, several lawmakers expressed their frustration with Schumer and the Senate for failing to include cannabis banking protections in the National Defense Authorization Act (NDAA).

Democrats have a very slim majority in the Senate and likely won’t be able to pass any cannabis bill without winning over GOP legislators. Furthermore, none of the GOP senators appointed to the conference have cosponsored the SAFE Banking Act, and Senate Minority leader Mitch McConnell has shown his displeasure at House Democrats including cannabis banking provisions in the America COMPETES Act. The fate of cannabis banking protections along with the concerns of marijuana industry actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) now remains in the hands of the negotiators who will work out a manufacturing law that can be approved for enactment.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Organa Kannalytics Releases Dates for 2022 Southeastern Hemp and Medical Cannabis Convention

Organa Kannalytics, an advocacy organization seeking to bring legitimacy to the hemp and medical cannabis industry through science and education, is hosting the upcoming Southeastern Hemp and Medical Cannabis (“SHMC”) Convention. The event is scheduled for May 12–14, 2022, and will be a live event held in Atlanta and streamed online. The event agenda includes inspiring speakers, insightful breakout sessions and invaluable networking opportunities, making this two-day gathering a can’t-miss convention. In-depth discussion will focus on medical use and practices, business opportunities in the hemp and cannabis space, scientific advancements, and local, state and national legislation impacting the growing cannabis and hemp industry. Speakers include Grammy award-winning producer Dallas Austin and former NFL wide receiver Tavarres King, who will be joined by renowned physicians and experts in the health and wellness, legal, business services, agriculture, regulatory, financial, technology, horticulture, quality assurance and research sectors within the hemp and medical cannabis industry. “We’re very pleased to be able to welcome everyone back to our live Southeastern Hemp and Medical Cannabis event for 2022, after postponing the conference scheduled last year due to the pandemic,” said Organa Kannalytics CEO Bridgett Graham in the press release. “Attending this event, in-person or online, will benefit entrepreneurs, growers, scientific professionals, suppliers and distributors as well as retail business owners in the hemp and medical cannabis industry, in addition to the consumers of their products and those searching for answers to their health and wellness issues.”

To view the full press release, visit https://cnw.fm/xuHDX

About Organa Kannalytics 

Organa Kannalytics, headquartered in Atlanta, is a consulting agency, medical cannabis dispensary and educational research center. The agency is the organizer of the annual Southeastern Hemp and Medical Cannabis conference. Organa Kannalytics’ mission is to bring legitimacy to the hemp and medical cannabis industry through science and education. For more information about the company, please visit www.OrganaKannalytics.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences Its Most Comprehensive Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has begun its multi-week human clinical hypertension study. The randomized, double blinded, placebo-controlled, cross-over study in 60 people, HYPER-H21-4, is the most comprehensive study ever undertaken by Lexaria. HYPER-H21-4 is designed to enhance Lexaria’s probability of success with its expected subsequent Investigational New Drug (“IND”) application filing to seek U.S. Food and Drug Administration (“FDA”) approval to commence registered clinical testing at phase I level or higher, to be determined in consultation with the FDA. The human study is also expected to enhance Lexaria’s understanding of DehydraTECH-CBD for the treatment of cardiovascular and other disease states beyond hypertension. Dosing has commenced in more than half of the HYPER-H21-4 volunteers, ahead of schedule, with all treatment visits expected to conclude in early July 2022. In addition, baseline brain magnetic resonance imaging (“MRI”) scanning has already begun. Of significant note, no serious adverse events have been reported by study volunteers, demonstrating that DehydraTECH-CBD has been well tolerated in those who have received it thus far.

To view the full press release, visit https://cnw.fm/AiwGy

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 24 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will be involved in several conferences in April and May. Company management will be participating at the Benzinga Spring Cannabis Capital Conference, scheduled for April 20–21, 2022, in Miami Beach, Florida. InMed executives will be meeting virtually with institutions and industry representatives. Company executives will also be at Canaccord Genuity’s sixth annual Global Cannabis Conference held on May 11, 2022. A recording of the company’s presentation will be available on InMed’s investor relations website following the event. Company leaders will also be available for virtual one-on-one meetings with institutional and corporate clients. In addition, InMed executives will participate at the H.C. Wainwright Global Investment Conference, held virtually May 23–26, 2022. A recording of InMed’s webcast will also be available on the company website following this event. In addition, InMed executives will be available for one-on-one meetings with institutional and corporate clients.

To view the full press release, visit https://cnw.fm/SuNKH

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.  

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lift&Co. Expo Toronto 2022 to Gather Experts from Canadian and Global Cannabis Ecosystem

Thousands of exhibitors, speakers and attendees from across the cannabis industry will soon gather for the much-awaited Lift&Co. Expo Toronto 2022, to be held from 12-15 May, 2022, in Toronto. Lift&Co. Expo is Canada’s leading cannabis conference and trade show, attended by top innovators, retailers, licensed producers, investors and regulators to share and discuss important topics and breakthroughs in the world of cannabis.

Lift&Co. Expo Toronto 2022 includes:​

  • Lift Cannabis Business Conference | May 12​
  • CannaVest North Investment Forum | May 13-14
  • Lift&Co. Expo Industry Days | May 13 – 14 
  • Budtender Day | May 14
  • Lift&Co. Expo Consumer Day | May 15​

The experienced team at Lift&Co. Expo works meticulously to produce one of the finest cannabis trade shows in North America, showcasing 250-plus industry exhibitors and 200-plus of the greatest names in the cannabis industry delivering insights and education. The show also provides unmatched business networking opportunities throughout its four-day run. 

The event begins with the Lift Cannabis Business Conference on 12 May, covering the cannabis industry in Canada through different perceptions and viewpoints. This conference will provide information on the latest opportunities, while exploring how Canadian businesses and investors can set up expansion plans and gain access to novel opportunities both locally and internationally. New this year, the CannaVest North Investment Forum, 13-14 May, will specifically gather cannabis companies looking to access capital with accredited investors.

Lift&Co. Expo offers an expansive arena to connect with potential businesses and investors, start a meaningful conversation and build long-term business ties. This is also an excellent stage that offers educational content and valuable insights into the future of evolving cannabis trade. Consumers and professionals can connect at Lift&Co. Expo to leverage this brilliant opportunity for networking in the cannabis ecosystem.

To learn more, please visit https://liftexpo.ca.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Why Women Use CBD Supplements Daily

More and more women are turning to a cannabis extract called cannabidiol (CBD) as an alternative treatment. Unlike THC, which is the main psychoactive element in cannabis, CBD does not intoxicate users. Studies have found that the cannabinoid has plenty of medical potential and can be used to alleviate conditions such as chronic pain and mood disorders, including PTSD, in place of conventional pharmaceutical treatments.

The medical and health and wellness industries have taken a particular liking to CBD due to its alleged medicinal properties. And, according to data from Ease Survey, female baby boomers account for a large percentage of cannabis users.

Another study revealed that while men are more likely to use cannabidiol for overall health and wellness, women tend to use it to alleviate medical conditions. This is probably because women have often lacked access to medical treatments, with most medical research being centered on men, which led females to seek alternative treatments.

Pain is one of the conditions that push people to CBD. A 2019 poll by Gallup found that 40% of CBD users utilize the cannabinoid for its pain-relieving abilities. On top of chronic conditions such as endometriosis and fibromyalgia, women are likely to experience pain due to the effect menstrual cycles have on their hormones. Fluctuating hormone levels can lead to low estrogen, which increases the body’s sensitivity to pain.

Women also have greater nerve density, which causes them to feel pain more intensely. Another reason women are more likely to turn to CBD supplements is pelvic pain, a condition that specifically affects women. A 2021 study done by University of Michigan researchers found that women with chronic pelvic pain regularly use CBD to alleviate their symptoms. An estimated 76% of the respondents revealed that they substituted pharmaceutical medications with CBD, and 81% said that the cannabinoid reduced their pain.

CBD has also shown potential in treating mood disorders, and plenty of women seem to have noticed. Compared to males, women are more likely to experience anxiety and depression throughout their lives with puberty, pregnancy, postpregnancy, perimenopause and menopause increasing the chances of depression significantly due to hormonal fluctuations. CBD can help regulate and balance these hormones.

Cannabidiol’s antioxidant, anti-inflammatory and analgesic properties make it great for treating skin conditions and promoting healthy skin. With companies developing a wide variety of CBD-infused skin products, such as salves, oils, balms and creams, women are using them to combat conditions, including eczema and psoriasis, and to reduce breakouts.

CBD lube can also help women enhance their sex lives. Alex Capano, the medical director at Ananda Hemp, says that because of the abundance of cannabinoid receptors in reproductive organs, CBD can boost blood flow, which increases sensitivity and natural lubrication. It can also help to reduce performance anxiety and increase muscle relaxation.

The analysis above sheds vital light on the different reasons why plenty of women could be buying CBD-rich products from licensed companies such as Flora Growth Corp. (NASDAQ: FLGC).

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — University of Mississippi Research Shows Marijuana Legalization Reduces Admissions in Foster Care

According to a recent study undertaken by University of Mississippi researchers, the legalization of cannabis, especially for recreational use by adults, is linked to a minimum of 10% reduction in the rates at which kids are admitted into foster care homes. These reductions occur for placements associated with neglect, physical abuse, abuse of drugs (excluding marijuana) or alcohol as well as for parental incarcerations.

The study further indicates that if marijuana were to be legalized federally, there would be massive savings with regard to the money injected into foster care each year. To arrive at these conclusions, the team of researchers collected data from several sources and then analyzed that data.

The authors reported that from their analysis, admissions to foster care drop by a minimum of 10% once marijuana is legalized, and bigger reductions occur several years after a jurisdiction has ended cannabis prohibition. The team compared the data for states with recreational cannabis markets and states that don’t have enabling cannabis laws for the recreational use of the substance.

Previous research suggests that each child placed into a foster-care family costs approximately $25,000 each year. Based on this estimate, the University of Mississippi team deducted that allowing adult-use marijuana can save the country approximately $675 million every year with regards to the funding that goes into sustaining the foster care systems.

One source of data for this research was the reporting system of the Adoption and Foster Care Analysis. The team accessed the records from this system spanning the period 2000 to 2017. They found that there was no statistically notable difference between the rates at which kids enter the foster care system in different states that don’t have recreational marijuana laws. However, admission reductions start gradually manifesting once legalization takes place.

Several possible explanations are offered for this occurrence. First, the researchers posit that allowing recreational cannabis can potentially reduce the likelihood that an individual will abuse other drugs. For instance, studies say legal access to recreational cannabis correlates with a reduction in the use of alcohol.

Also, cases of kids going into foster care due to the imprisonment of their parents or other related causes tend to decrease when recreational marijuana is legal. However, the researchers are quick to note that they aren’t sure exactly how these “knock-on” effects occur and further research is needed to understand any causal relationships between full cannabis legalization and issues such as parental neglect, physical abuse and so on.

For now, it looks like enacting recreational cannabis laws and allowing entities such as American Cannabis Partners to operate seems to be good for society, especially in terms of lowering the incidence of kids ending up in foster care.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale

InMed Pharmaceuticals (NASDAQ: INM), a rare cannabinoid drug developer, is expanding its product manufacturing scale, thanks largely to the acquisition of consumer-focused rare cannabinoids manufacturer BayMedica last year. “InMed’s most-recent Q2 financial statement reported revenues of $0.3 million from commercial sales of cannabichromene (‘CBC’) to the health and wellness market following the BayMedica acquisition. Since January, the company has also been selling cannabicitran (‘CBT’) to the health and wellness market on a B2B basis,” a recent article reads. “The company’s forward-looking focus on bringing new cannabinoid products to commercial scale anticipates scales of cannabidivarin (‘CBDV’) and tetrahydrocannabivarin (‘THCV’) in the coming months as its next revenue generators…. The company expects to produce more than 100 kilograms of CBDV and THCV under the initiative. Because of the very limited quantities of rare cannabinoids that make them effectively impractical from an economic standpoint to extract directly from the plant for pharmaceutical use, InMed’s R&D operation is working to develop synthetic formulations for the treatment of specific conditions.”

To view the full article, visit https://cnw.fm/fTNC8

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is also a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.InMedPharma.com and www.BayMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on ‘Solid Ground in 2022 and Beyond’

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a company positioning itself to be one of the top three multistate operators in the United States in cannabis and hemp-derived product lines, has adopted a strategy anchored in operating a house of brands as it anticipates the commoditization of the cannabis market. “This is going to be a commoditized market, and our strategy is such that we are going to stand on our brands going forward. We just need to fortify what we are doing in the markets that we are in right now,” a recent article quotes RWB CEO Brad Rogers in his closing remarks issued during a November corporate update call. “This company has been building… and we’ll catch up with respect to where we want to be. So, when we look across 2021, the new acquisitions, the markets, etc., we’ve been building towards that. We have now set the stage in the form of infrastructure to start reporting all revenues and assets of these businesses, most of the one-time expenses and large non-cash items are behind us, putting us on solid ground in 2022 and beyond.”

To view the full article, visit https://cnw.fm/NzbMr

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Illinois, Oklahoma, and Michigan with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.